INDIAGLYCO India Glycols Q4 FY25 results (Jan–Mar 2025) and concall
India Glycols reported a strong full year FY25 performance with net sales growing 14% to INR 3,767 crores and standalone EBITDA increasing 23% to INR 521 crores. Q4 FY25 saw a 32% rise in EBITDA to INR 145 crores despite a 7% decline in net sales to INR 863 crores. The Bio-Fuels and Potable Spirits segments were key growth drivers, with Bio-Fuels revenue more than doubling and Potable Spirits growing over 22% for the full year. The joint venture also showed significant improvement, nearly tripling its net profit.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 961 | 975 | 863 |
| EBITDA | 116 | 124 | 144 |
| Net profit | 39 | 44 | 50 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
